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tlanta, Georgia
bjectives We sought to evaluate coronary epicardial and intramyocardial resistance, arterial vaso-
otor function, local inﬂammatory reaction, and superoxide anion (O2
·) production after overlap-
ing paclitaxel-eluting stent (PES) implantation in a porcine model.
ackground PES implantation has been shown to elicit coronary vasomotor dysfunction. However,
nderlying mechanisms remain largely unknown.
ethods Nine pigs received overlapping PES and bare-metal stents (BMS) in the coronary arteries,
nd 3 sham animals were naïve. At 1 month, inﬂammatory response at the overlapped region was
ssessed by histopathology and scanning electron microscopy. Endothelial vasomotor function and
2
· at nonstented coronary reference segments were measured by angiography and organ cham-
er tensiometry, and lucigenin luminometry; vasomotor function of distal resistance arteries was
easured by myography.
esults Paclitaxel-eluting stents showed reduced late lumen loss, but inﬂammation and luminal
nﬂammatory cell adherence were higher than for BMS (p  0.001) at overlapped segments. Endo-
helium-dependent relaxation to substance P was signiﬁcantly impaired in PES at nonstented coro-
ary reference segments (15 mm proximally and distally) and perfusion bed resistance arteries
p  0.05). In contrast, endothelium-independent relaxation to nitroglycerin and sodium-nitroprus-
ide was similar between groups. Local O2
· production at both proximal and distal nonstented cor-
nary reference segments was elevated for PES when compared with O2
· production in BMS and
aïve arteries (p  0.001).
onclusions Abnormal endothelium-dependent relaxation at both coronary conduit and resistance
rteries was demonstrated after overlapping PES implantation. Profound localized inﬂammatory re-
ction, as well as enhanced local oxidative stress, may contribute to vasomotor dysfunction. (J Am
oll Cardiol Intv 2009;2:253–62) © 2009 by the American College of Cardiology Foundation
rom Saint Joseph’s Translational Research Institute/Saint Joseph’s Hospital of Atlanta, Georgia. Supported by a Saint Joseph’s
ranslational Research Institute research grant, but contents of the manuscript are solely the responsibility of the authors. Steven
issen, MD, MACC, served as Guest Editor for this paper.anuscript received November 4, 2008, accepted November 5, 2008.
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TAXUS and Coronary Vasomotor Dysfunction
254he present generation of paclitaxel-eluting stents (PES)
rovides dramatic reductions in in-stent restenosis and target
esion revascularization rates compared with these rates in bare-
etal stents (BMS) (1–5). However, possible interaction of the
otent antiproliferative agent and permanent nonbiodegrad-
ble synthetic polymer have raised concerns regarding delayed
rterial healing and poor re-endothelialization, which may lead
o impaired endothelial function at and adjacent to the stent
ite (6–8). Overlapping stents are at times required for diffuse
nd long coronary lesions. The incidence of overlapping stent
lacement is up to 28% in TAXUS V and VI trials (9,10).
ncreased local drug concentration and polymer burden at
verlapped regions may elicit further delay in vessel recovery
specially impaired re-endothelialization.
Recently, a growing body of
clinical data has shown that com-
pared with BMS, PES implanta-
tion may elicit coronary conduit
artery vasomotor dysfunction at
nonstented reference segments
(NSRS) as late as 12 months after
implantation (11,12). The mech-
anism of this phenomenon is still
not fully understood. Healthy en-
dothelium generates nitric oxide
(NO), which maintains vascular
homeostasis and normal vaso-
motor tone. In pathophysiologic
situations, excess generation of
reactive free radicals especially su-
peroxide anion (O2
·), may de-
crease NO bioactivity and bio-
availability (13). The resultant
impairment of endothelial func-
tion is associated with inflamma-
tion and thrombogenicity, as well
as paradoxical vasoconstriction to
acetylcholine or exercise (14).
To date, systematic investigation
of vasoreactivity to endothelium-
ependent vasodilators in vivo and in vitro following overlapping
ES has not been reported. Therefore, in the present study, we
imed to evaluate: 1) inflammatory response at the PES-
verlapped region; 2) coronary artery and intramyocardial resis-
ance artery vasomotor function; as well as 3) coronary artery
uperoxide anion (O2
·) production, 1 month after overlapping
ES in porcine coronary model.
ethods
nimals and Experimental Protocol
nimal handling and care followed the recommendations of
bbreviations
nd Acronyms
MS  bare-metal stent(s)
ES  drug-eluting stent(s)
DdR  endothelium-
ependent relaxation
DiR  endothelium-
ndependent relaxation
T  endothelin
EPES  N-(2-hydroxyethyl)-
-piperazine ethanesulfonic
cid
O  nitric oxide
SRS  nonstented
eference segment
TG  nitroglycerin
ES  paclitaxel-eluting
tent(s)
G  prostaglandin
LU  relative light unit
EM  scanning electron
icroscopy
MC  smooth muscle cell
P  substance Phe National Institutes of Health guide for the care and use tf laboratory animals and was consistent with guidelines of
he American Heart Association. All protocols were ap-
roved by the Animal Care and Use Committee and were
onsistent with Association for Assessment and Accredita-
ion of Laboratory Animal Care guidelines. Twelve juvenile
emale or castrated male Yorkshire farm pigs (36  1.8 kg)
ere enrolled in this study.
Twelve animals were used in this study. Six pigs received
verlapping stent pairs in each of 2 coronary arteries with
andomization to BMS or PES by vessel; adjacent arterial
egments were used for vasomotor function and luminom-
try as shown in Figure 1. Three pigs were normal,
nstented age-matched naïve controls, with arterial seg-
ents for vasomotor function and luminometry used in the
ame manner as for stented pigs. Three pigs were used for
canning electron microscopic evaluation of the stent seg-
ent luminal surface.
Animals received a combination of 81-mg aspirin and
5-mg clopidogrel by mouth daily for 3 days before stenting
nd continued until termination. All pigs were fasted
vernight before the stent implant procedure. They were
edated by intramuscular injection of ketamine 20 mg/kg,
ylazine 2 mg/kg, and atropine 0.05 mg/kg. After intuba-
ion, general anesthesia was induced and maintained with
soflurane (2.5%). Electrocardiogram and blood pressure
ere continuously monitored.
As previously described by our group (15), cardiac cath-
terization was performed with full heparinization (200
/kg), and stents were implanted using quantitative coro-
ary angiography guidance to obtain a stent-to-artery di-
meter ratio 1.1:1 to 1.2:1. Overlapping PES (TAXUS,
oston Scientific Corp., Natick, Massachusetts) or BMS
Express 2, Boston Scientific Corp.) were implanted using
tandard techniques in 9 pigs (2 pairs of overlapping stents
er animal). There were no between-groups differences for
he total stent length (PES: 26.8  0.4 mm vs. BMS: 26.0
0.6 mm, p  0.28), stent overlap length (PES: 5.2  0.4
m vs. BMS: 5.1  0.4 mm, p  0.85), or angiographic
tent-to-artery diameter ratio (PES: 1.14  0.02 vs. BMS:
.14  0.01, p  0.11). After late lumen loss measurement
nd in vivo vascular function studies at 1 month, the animals
ere terminated.
istopathology Analysis
tented segments for histopathologic analysis were excised
nd fixed with a mixture of buffered 1.25% glutaraldehyde
nd 5% formalin. After dehydration in graded ethanol series
o 100%, stented vessels were embedded in methyl methac-
ylate. Sections from the overlapped-stent region were cut
sing a heavy-duty microtome, collected on glass slides, and
tained with hematoxylin-eosin and Movat-Pentachrome.
ccording to previously published methods (16), intramuralhrombus (a mixture of fibrin, para-strut amorphous mate-
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255ial and red blood cell debris) and inflammation were scored
n all sections: 0  not present; 1  mild (scattered); 2 
oderate (encompassing 50% of a strut in at least 25% to
0% of the circumference length); and 3  severe (sur-
ounding a strut in at least 50% of the circumference
ength). Similarly, necrosis of the tunica media was also
cored: 0  none; 1  mild [focal transmural or nontrans-
ural region of medial smooth muscle cell (SMC) necrosis
nvolving any portion of the artery]; 2  moderate (trans-
ural medial SMC necrosis involving25% of the circum-
erence of the artery); and 3  severe (transmural medial
MC necrosis with involvement of 50% of the circum-
erence of the artery).
canning Electron Microscopy Evaluation
hree stents from each PES and BMS group were pro-
essed for scanning electron microscopy (SEM) to assess the
resence of adherent inflammatory cells on the luminal
urface at the overlapped region. The stented vessels were
xcised into 2 longitudinal hemisections, exposing the
oronary luminal surface. Samples were fixed with 2.5%
lutaraldehyde, rinsed with cacodylate buffer (pH 7.4), and
ost-fixed for 1 h in 1% OsO4. After serial ethanol dehy-
ration, the samples were critical-point dried from liquid
O2, attached to aluminum support stubs, and magnetron
putter-coated with 25-nm gold. Luminal surfaces were
xamined in a Topcon DS-130 SEM (Topcon Co., Ltd.,
okyo, Japan), and digital images were recorded and as-
Figure 1. Macroscopy of the Dissected Coronary Segments With Study Flo
(A) Site of overlapped stented segment (red box); areas of nonstented referen
stented segment used for measurement of superoxide (green arrow). (B) PES
for in vivo and in vitro studies. BMS  bare-metal stent(s); PES  paclitaxel-eluessed. The density of the inflammatory cells was counted in lhe overlapping region and expressed as cells per square
illimeter.
ascular Endothelial Function
picardial artery. ANGIOGRAM IN VIVO. At termination,
ndothelium-dependent (EDdR) and -independent (EDiR)
oronary vasorelaxation responses were assessed after intra-
oronary infusion of the endothelium-dependent receptor-
ediated dilator substance P ([sP] 2 ng/kg) followed by the
ndothelium-independent vasodilator nitroglycerin ([NTG]
00 g) administered via guide catheter. Substance P was
nfused over 30 s (17). After a 10-min interval, NTG was
dministered as a bolus. Coronary angiography was per-
ormed using identical angiographic projections before and
fter drug administration. The percent diameter change
rom baseline to post-infusion was measured at NSRS (1.5
m proximal and distal to the stent). Vasorelaxation was also
easured for the naïve group at similar locations.
RGAN CHAMBER APPARATUS IN VITRO. Hearts were har-
ested and placed in ice-cold Krebs solution. Coronary
rtery segments (PES [n  12], BMS [n  12], and naïve
n  6] rings per group, equally divided into proximal and
istal) at similar locations as for the in vivo study were
leaned of loose fat and connective tissue. The specimens
ere then cut into 4-mm long rings and suspended in
ndividual organ chambers (Radnoti Glass Technology,
onrovia, California) filled with 17-ml freshly made Krebs
olution with the following composition (millimoles per
rt
gments used for vasomotor functional testing (red arrow); areas of non-
C) BMS images of isolated coronary stented and nonstented segments used
tent(s); SEM  scanning electron microscopy.w Cha
ce se
and (iter): NaCl 120, MgSO4 1.17, KH2PO4 1.18, NaHCO3
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2565.0, CaCl2 2.5, KCl 4.7, glucose 5.5, and 10-mol/l
ndomethacin at pH 7.4 (18) and oxygenated with 95% O2
nd 5% CO2 at 37°C. Vessel rings were gradually stretched
o a basal tension of 4 g, which was continuously adjusted
ver approximately 90 min until stable. Vessels were kept at
he same passive tension of 4 g throughout the remainder of
he study; Krebs buffer was changed every 15 min during the
quilibration period.
Contraction was tested with 40- and 100-mmol/l KCl.
ings were then pre-constricted with a single dose (5
mol/l) of prostaglandin (PG) F2-alpha until they reached a
table plateau. Then EDdR and EdiR were tested by
ncremental logarithmic concentrations of sP (0.01 to 100
mol/l), A23187 (0.03 to 3 mol/l), and sodium nitroprus-
ide (0.001 to 10 mol/l). After incubation with 100-
mol/l NW-nitro-L-arginine methyl ester (a competitive
nhibitor of NO synthase) for 45 min, sP concentration-
esponse curves were repeated. The rings were then con-
racted with 0.1-mol/l endothelin-1 (ET-1) at the end of
ach experiment. Vessels were washed for 45 min between
ach concentration-response curve. Isometric tension was
igitized, acquired, and analyzed using a Ponemah Tissue
latform System (Gould Instrument System, Valley View,
hio).
YOGRAPH ANALYSIS IN VITRO. Fifteen microvessel rings
3 naïve, 6 BMS, and 6 PES) harvested 1 month post-stent
mplantation were studied. Myocardial sections 1.5  1.5
m in size were dissected under a stereomicroscope and
esistance arteries (lumen diameter 250 m) were iso-
ated. The resistance arteries were sampled in the circulatory
istribution of the stented vessel by identifying at least 1
picardial artery branching from the stented conduit artery,
hen tracking distal to this branch to obtain the sample.
etal wires (40-m diameter) were passed through each
umen; 1 wire was mounted on the micrometer and the
ther on the transducer block side. The vessels were studied
n 610M myograph apparatus (Danish Myo Technology,
arhus, Denmark). Once microvessels were stretched to
asal tension of 1 g, vasomotor responses were measured in
similar fashion as conduit arteries. Isometric tension was
igitized, acquired, and analyzed using a PowerLab system
ADInstruments, Inc., Colorado Springs, Colorado).
etection of Oxidative Stress
uperoxide anion (O2
· ) production (PES [n  12], BMS
n  12], and naïve [n  6]) rings per group, equally
ivided into proximal and distal) was estimated by the
reviously described lucigenin chemiluminescence method
19) with a luminometer (Zylux Corp., Oak Ridge, Ten-
essee). Proximal and distal NSRS were cut into 4-mm long
ings. An assay tube was filled with Krebs–N-(2-
ydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES)
uffer, made by NaCl 99.0, KCl 4.69, CaCl2 2.5, MgSO4 t.2, NaHCO3 25.0, K2HPO4 1.03, Na-HEPES 20.0 and
lucose 11.1 (mmol/l, pH 7.35), and lucigenin solution with
nal concentration of 5 mol/l. Samples were assayed at
7°C in a dark room. Time-dependent output of the
uminometer was recorded. Data was expressed in relative
ight units (RLU) per second for each of the samples;
amples were dried at room temperature for 24 h and
eighed (milligrams). Final results (in RLU per second per
illigram) were calculated as: (Krebs-HEPES plus
-mol/l lucigenin reading – Krebs-HEPES reading)/dry
eight.
tatistical Analysis
ata were expressed as mean  standard error. Statistical
nalysis was performed by Sigma Stat version 3.5 (Systat
oftware, Inc., Chicago, Illinois). Comparisons between 2
tent groups or stent and naïve group measurements were
erformed by the Student paired or unpaired 2-tailed t test.
critical value of p  0.05 was considered to indicate
ignificant treatment effect or between-groups difference.
he authors had full access to and take full responsibility for
he integrity of the data. All authors have read and agree to
he manuscript as written.
esults
ngiography, Histopathology and SEM Findings
n Overlapped Regions
ll vessels were angiographically patent at 28 days after
mplantation. The late lumen loss was significantly reduced
or PES (0.46  0.21 mm) in comparison to BMS (1.30 
.16 mm, p  0.001) at overlapped segments.
On gross examination, perivascular adhesions and hem-
rrhages were found only at the stented segments in PES
ut not BMS. Under microscopy, a mixture of para-strut
brin, amorphous material, erythrocyte debris, widespread
essel wall inflammatory cell infiltration, as well as focal
edial necrosis beneath the stent struts were evident in the
ES group. Histopathologic scoring is shown in Figure 2.
otably, the degrees of inflammation, intramural thrombus,
nd medial necrosis were all increased in PES compared
ith BMS at the site of overlapping segments (p  0.001
or all comparisons). For within-group comparison, the
nflammation and medial necrosis scores were similar for the
onoverlapped and overlapped segments of PES. However,
he intramural thrombosis in the overlapped area was
reater than nonoverlapped regions (p  0.05). Inflamma-
ory cells, primarily neutrophils, eosinophils, monocyte-
acrophages, as well as giant cells, and such, were noted in
eointima of PES. The BMS showed fibrocellular neoin-
ima formation with proteoglycan-rich and collagenous
atrix, with minimal inflammatory cell infiltration and mildunica media compression at the site of stent strut contact.
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257n accordance with histopathology scoring, inflammatory
ell density on luminal surface at overlapped area assessed by
EM was also markedly increased in PES versus BMS
1,733  128/mm2 vs. 183  56/mm2, p  0.00001).
epresentative histological and SEM sections of proximal,
verlapped, as well as distal stented segments of PES and
MS are shown in Figures 3 and 4.
ascular Endothelial Function
ngiographic evaluation. There were no between-groups
ifferences in lumen diameter at baseline for either proximal
PES: 3.07  0.11 mm, BMS: 3.12  0.06 mm, and naïve:
.00 0.11 mm; p NS) or distal (PES: 2.98 0.12 mm,
MS: 2.83  0.11 mm, and naïve: 2.83  0.07 mm; p 
Figure 2. Histopathologic Scoring
Stacked column graph showing grading from 0 to 3 in all analyzed sec-
tions from each stent type for (A) inﬂammation score, (B) intramural
thrombi, and (C) medial necrosis. In all 3 categories, when compared with
BMS, PES showed signiﬁcant difference (p  0.001 for all 3). Abbreviations
as in Figure 1.S) NSRS. No notable heart rate or mean blood pressurehanges were detected after intracoronary injection of either
P or NTG.
Although vasodilation occurred with both sP and NTG,
ndothelium-dependent diameter change in response to the
ormer was diminished for PES arteries when compared
ith BMS and naïve arteries. Diameter increase was 0.4 
% for PES (p  0.007) versus 10  2% for BMS and 15
3% for naïve vessels at proximal NSRS (p  0.001), with
similar pattern seen at distal NSRS (0.3  3% for PES,
 0.019; 10  2% for BMS and 15  4% for naïve, p 
.007). Conversely, NTG-induced EDiR was comparable
mong PES, BMS, and naïve groups at both proximal
PES: 11  1%, BMS: 12  2%, and naïve: 18  3%; p 
S) and distal (PES: 10  2%, BMS: 14  2%, and naïve:
8  4%; p  NS) NSRS.
picardial conduit artery responses in vitro. The BMS and
aïve arteries relaxed in a dose-dependent manner to sP, a
eceptor-mediated EDdR (Figs. 5A and 5B). However, for
oth proximal and distal NSRS, cumulative concentration
urves were significantly shifted. The PES vessels showed
ignificantly reduced relaxation at maximal sP concentration
ompared with relaxation at maximal sP concentration in
MS and naïve vessels (proximal: PES: 38.3  5%, p 
Figure 3. Histology M-P Staining
High magniﬁcation (100) microscopic images of M-P–stained sections
from proximal, overlapping, and distal sections in PES and BMS demon-
strated overall vessel morphologies. Although the neointimal growth was
suppressed in PES when compared with BMS, the intramural thrombosis in
the overlapped area was greater than in nonoverlapped regions. M-P 
Movat-Pentachrome staining; other abbreviations as in Figure 1.
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258.05, vs. BMS: 60  7% and naïve: 81.5  2%, p  0.001;
istal: PES: 30.9  3%, p  0.05, vs. BMS: 55.7  8% and
aïve: 82 2%, p 0.001). The vascular responses of BMS
nd naïve arteries to calcium-ionophore (A23187, a nonre-
eptor mediated vasodilator) were similar (proximal: BMS:
3.6 4% vs. naïve: 86.3 2%; p NS; distal: BMS: 81.5
5% vs. naïve: 84.2  1%, p  NS), whereas the maximal
elaxation of the PES group was significantly diminished as
ompared with relaxation in the BMS and naïve groups
proximal: 57  4%, p  0.001 vs. naïve and BMS; distal:
1.8  7%, p  0.05 vs. naïve and BMS) (Figs. 5C and
D). Maximal EDiR in reaction to sodium nitroprusside
Figure 4. Histology H&E Staining and SEM
(A and B) High magniﬁcation (100) microscopic images of H&E-stained
overlapped sections from coronary segments implanted with PES and BMS.
(C and D) High magniﬁcation (400) microscopic images of H&E-stained
sections of BMS segments exhibited well-healed, thick ﬁbrocellular neoin-
tima, completely covered with endothelial or endothelial-like cells. Small
amounts of inspissated thrombus and ﬁbrin deposits were observed (C). In
PES, drug effect was clearly apparent for all of the overlapping PES in the
form of a mixture of para-strut ﬁbrin, amorphous material, and red blood
cell debris, as well as widespread inﬂammatory cell inﬁltration (several
large round mononuclear cells, black arrows) into vessel wall and focal
medial necrosis beneath the stent struts. (E and F) Scanning electron
microscopy shows overlapped region for both BMS and PES at 1 month. In
contrast to BMS (E), PES (F) displayed dramatically more inﬂammatory cell
density on the luminal surface (bar indicates 40 m). H&E  hematoxylin-
eosin staining; other abbreviations as in Figure 1.as similar among groups (proximal: PES: 83.9  3% vs. aMS: 90.8  1% and naïve: 93.6  3%, p  NS; distal:
ES: 86.4  3% vs. BMS: 85.3  2% and naïve: 92.8 
%, p NS) (Figs. 5E and 5F). In addition, concentration-
ependent relaxation to sP at both proximal and distal
SRS in PES was abrogated by pre-incubation with NW-
itro-L-arginine methyl ester.
Contractile responses to PGF2-alpha and ET-1 were
ignificantly increased in both proximal and distal PES-
SRS, compared with response in BMS and naïve vessels
p  0.001). The ratio of contraction to ET-1 compared
ith contraction to 40-mmol/l KCl was greater for PES
han for BMS and naïve (proximal: 1.52  0.05 for PES vs.
.97 0.09 for BMS and 0.85 0.05 for naïve, p 0.001;
istal: 3.29  0.58 for PES vs. 1.3  0.10 for BMS and
.90  0.07 for naïve, p  0.001). Baseline ratio of
-mol/l PGF2-alpha–induced contraction to 40-mmol/l
Cl–induced contraction was increased in PES (proximal:
.70 0.07% for PES, 0.50 0.02% for BMS, and 0.41
.02% for naïve, p  0.001; distal: 1.03  0.02% for PES,
.56  0.03% for BMS, and 0.50  0.08% for naïve, p 
.001).
yograph analysis of intramyocardial microvascular resis-
ance arteries. Like epicardial conduit arteries, microvessels
n the perfusion bed for BMS and naïve arteries relaxed in
dose-dependent manner to sP (Fig. 6A). However, relax-
tion response to maximal sP was impaired for PES vessels
hen compared BMS and naïve vessels (56 11% for PES,
 0.05; 86  6% for BMS and 105  3% for naïve, p 
.001). With calcium-ionophore, relaxation response was
educed in PES compared with naïve (A23187) vessels (65
12% for PES, p  0.14; 96  15 for BMS and 112  3
or naïve, p  0.001) (Fig. 6B). Maximal EDiR at mi-
rovessel level in reaction to sodium nitroprusside was
imilar among groups (Fig. 6C). Contraction response to
T-1 was similar among the groups.
uperoxide anion (O2
· ) Production of
oronary Conduit Arteries
s shown in Figure 7, overlapping PES implantation at 1
onth induced a marked increase in O2
·  production at
oth proximal and distal NSRS, as measured by lucigenin
hemiluminescence (proximal: PES: 36.2  3.3 vs. BMS:
4.6  2., and naïve: 12.4  1.2 RLU/s/mg tissue; p 
.001) and (distal: PES: 77.2  4.0 vs. BMS: 23.2  5.4,
nd naïve: 19.5  0.6 RLU/s/mg tissue; p  0.001).
iscussion
sing both in vivo and in vitro methods, we have performed
he first systematic evaluation of vasomotor function of
oronary epicardial arteries both at proximal and distal
SRS, as well as perfusion bed intramyocardial resistancerteries, after overlapping PES implantation in laboratory
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259Figure 5. In Vitro Relaxation Responses of Coronary Segments Proximal and Distal to Stents
Cumulative concentration-relaxation curves for coronary artery segments proximal and distal to PES and BMS and naïve vessels. (A and B) Relaxation to higher
concentrations of endothelium-dependent vasodilator sP was inhibited in coronary segments both proximal and distal to PES compared with relaxation in BMS
(p  0.05) and naïve (p  0.001) vessels from 1012 to 1010. (C and D) Relaxation to higher concentrations of endothelium-dependent (nonreceptor mediated)
vasodilator A23187 was inhibited in coronary segments both proximal and distal to PES compared with relaxation in BMS (p  0.001) and naïve (p  0.001) ves-
sels from 106 to 3  106. (E and F) Relaxation to the highest concentration of the endothelium-independent dilator sodium nitroprusside was similar for PES,
BMS, and naïve vessels (p  NS). sP  substance P; other abbreviations as in Figure 1.
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usimilar for PES, BMS, and naïve vessels (p  NS). Abbreviations as in Figure 1.
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260wine. Additionally, we specifically analyzed the inflamma-
ory response at overlapped region and superoxide anion
roduction at both proximal and distal NSRS. Our data
emonstrate that although overlapping PES is effective in
nhibiting neointimal growth, a profound adverse effect on
asomotor function was observed in both conduit and
esistance arteries distant from the site of direct mechanical
njury. Such widespread influence on vasomotor function
rom the stented coronary artery appears to be associated
ith extensive localized inflammation at the stent site, as
ell as increased O2
·  production in the reference coronary
rteries.
Consistent with our findings, 2 recent clinical investiga-
ions demonstrated that PES implantation was associated
ith long-term coronary endothelial dysfunction when
ompared with the BMS counterpart. Togni et al. (11),
Figure 7. Superoxide Anion (O2
· ) Production Proximal and Distal to
the Stent
Increased O2
· production at both proximal and distal segments immedi-
ately adjacent to stent measured by lucigenin chemiluminescence in PES
(proximal: p  0.001; distal: p  0.001) compared with O2
· production in
BMS and naïve vessels (proximal: p  0.001; distal: p  0.001). RLU  rela-
tive light units; other abbreviations as in Figure 1.Figure 6. In Vitro Relaxation Responses of Intramyocardial Resistance
Arteries Distal to Stents
Cumulative concentration-relaxation curves for microvascular arteries distal to
PES and BMS, and naïve vessels. (A) Relaxation to higher concentrations of
endothelium-dependent vasodilator sP was inhibited in PES compared with
relaxation in BMS (p  0.05) and naïve (p  0.001) vessels. (B) Relaxation to
higher concentrations of endothelium-dependent (nonreceptor mediated)
vasodilator A23187 was inhibited in coronary segments distal to PES compared
with relaxation of naïve vessels (p  0.05). (C) Relaxation to the highest con-
centration of the endothelium-independent dilator sodium nitroprusside wassing exercise-induced flow-mediated EDdR, observed par-
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261doxical vasoconstriction response in the peri-stent seg-
ents after PES placement at 2 to 12 months, while BMS
esponses were normal. Similarly, Shin et al. (12) reported
oth TAXUS and Cypher (sirolimus-eluting) stents showed
mpairment of EDdR response to acetylcholine in distal and
ven far distal NSRS at 6 to 9 months. In agreement with
ur myograph findings, alterations in microcirculation re-
ponses following both TAXUS and Cypher implantation
ere identified; these investigators found that collateral
unction, measured by collateral flow index, 6 months after
rug-eluting stent (DES) was dramatically lower than seen
fter BMS implantation (20).
Molecular mechanisms of vascular endothelial impair-
ent following DES remain incompletely defined, yet our
nvestigation provides clues into its etiology. Aside from the
etal struts, PES contains 2 important components: non-
iodegradable synthetic polymer and paclitaxel. Due to the
olymer lipophilicity, only 10% of the initial drug dose can
e released from the current slow-release formulation of
AXUS, leaving the residual 90% of the drug in a tissue-
ound form (16,21). Multiple factors, including direct toxic
ffect from the entrapped drug or an acute or delayed
ypersensitivity reaction from the polymer and/or drug, may
ause DES-triggered vasomotor dysfunction. As recently
hown, the vasa vasorum interna in porcine coronary arteries
riginating directly from the arterial lumen can extend over
everal centimeters along the coronary artery wall. There-
ore, the antiproliferative drug may locally diffuse through
asa vasorum to the NSRS (22,23).
By in vitro cell assay, Axel et al. (24) demonstrated
igh-dose paclitaxel to be a potent inhibitor of not only
MC, but also of endothelial cell, proliferation and migra-
ion. Correspondingly, Farb et al. (25) have shown a
ose-dependent decrease in neointimal formation and sub-
equent increase in vessel wall toxicity from paclitaxel in a
orcine coronary model. In the present study, we also
onfirmed, by histopathology and SEM, that the overlap-
ing PES region (relatively higher doses of drug and
olymer) had more pronounced inflammatory and toxic
eaction than the BMS and naïve vessels do. It has been
emonstrated that increased inflammatory burden is asso-
iated with increased production of reactive oxygen species.
otur-Stevuljevic et al. (26) evidenced that the oxidative
tress markers positively correlated with inflammatory
arkers as a consequence of inflammatory processes in
ascular tissue. Superoxide anion, now recognized as a
undamental free radical, is an active participant in oxidative
tress states. Oxidative stress via oxygen free radical produc-
ion, such as superoxide anion, depletes NO reserves,
ltimately resulting in endothelial dysfunction (27).
The endothelial permeability barrier is established and
aintained primarily by endothelium-to-endothelium junc-
ional structures including adherens junctions, tight junc-
ions, desmosomes, and gap junctions. Recently, O2
·  also cas been shown to directly damage the endothelial barrier
28). Many cell types, especially inflammatory cells, are
apable of O2
·  generation (29). Passage of macromole-
ules, including vasoactive peptides, proteins, and other
eactive compounds into the arterial tissue, is therefore
nhanced in this pathophysiologic scenario.
A notable finding of the present study therefore, and
otentially pivotal to the elucidation of DES-associated
asomotor pathophysiology, is the significantly higher level
f O2
·  in conduit arteries proximal and distal to PES,
ompared with levels of O2
· BMS and naïve vessels. Due to
hronically increased production of reactive oxygen species,
O bioavailability may be decreased secondary to inactivation
y O2
·, resulting in impairment of endothelium-mediated
ascular relaxation response. The importance of NO for EDdR
lso was confirmed in our experiment by the complete blockage
f vasorelaxation in the presence of endothelial NO synthase
lockade by NW-nitro-L-arginine methyl esterin PES. Thus,
nderlying direct drug toxicity and/or polymer incompatibility,
otentiation of superoxide activity may be a culprit mechanism
o endothelial dysfunction.
Beyond vasorelaxation dysfunction, our data also illus-
rated significantly increased contractile response to PG
2-alpha and ET-1 in the both the proximal and distal NSRS
or PES. This paradoxical vasoconstrictive response in
SRS may potentially lead to stasis of coronary blood flow,
hich has been well-documented in clinical case studies
30). The potential contribution of such flow impairment to
ES thrombosis is unknown but should be more exten-
ively evaluated in future studies.
tudy limitations. First, animal models do not precisely
imulate responses to DES in humans. Normal porcine
oronary arteries are not representative of the diseased
uman coronary system, which consists of lipid-rich ath-
rosclerotic and potentially thrombotic stenotic lesions.
econd, longer-term studies are needed to address potential
ndothelial functional recovery at later time points. Finally,
he relatively small number of animal subjects should be
onsidered when interpreting these results.
onclusions
lthough the PES were effective in reducing neointima
ormation, profound adverse effects were noted on vasomo-
or function involving arterial segments both proximal and
istal to the stent at the coronary conduit artery level.
icrocirculatory dysfunction was also noted in the perfu-
ion distribution of the stented segment in the form of
mpaired relaxation. Oxidative stress from increased free
adical production is likely an underlying mechanism for
onduit artery endothelial dysfunction.
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